NIH Highlighted Topic: Enhancing Scientific Rigor, Transparency and Replicability
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The National Institutes of Health (NIH) is encouraging innovative research proposals focused on improving scientific rigor, transparency, reproducibility, and replicability across the biomedical research enterprise. This highlighted topic supports multidisciplinary projects that develop new tools, standards, methodologies, training programs, AI-enabled systems, and collaborative frameworks designed to strengthen the quality, validity, and reliability of scientific research outcomes.
NIH recognizes that reproducible and transparent research practices are essential for accelerating biomedical discovery, improving translational success, reducing bias, and maximizing public trust in science. The initiative is particularly interested in technologies and strategies that improve experimental design, metadata quality, protocol standardization, analytical reproducibility, AI validation, data interoperability, and dissemination of rigorous scientific practices.
Companies developing AI-driven research platforms, scientific workflow software, reproducibility analytics systems, metadata infrastructure, laboratory automation tools, benchmarking frameworks, biomedical informatics systems, open science technologies, or research collaboration platforms may be strong candidates for funding.
Areas of interest include AI-assisted rigor assessment, FAIR and TRUST-aligned data standards, automated metadata generation, reproducibility benchmarking, workflow traceability, protocol sharing, sex as a biological variable (SABV) frameworks, community-based training systems, common data elements (CDEs), multimodal data harmonization, laboratory automation, digital provenance tracking, and implementation science approaches that improve adoption of rigorous research practices. NIH is also encouraging projects supporting reproducibility in genomics, neuroscience, mental health, environmental health, imaging, clinical trials, aging, substance use research, and AI/ML evaluation frameworks.
Funding is available through the NIH SBIR/STTR Program and related NIH research, education, and conference mechanisms, including opportunities for Phase I and Phase II commercialization support depending on project scope and translational impact.
This highlighted topic is supported by a broad coalition of NIH Institutes and Offices including NINDS, NLM, NIBIB, NHGRI, NCI, NHLBI, NIA, NIMH, NIDA, NIAID, NEI, NCCIH, ORWH, ODSS, ODP, ODS, NIGMS, NIEHS, and many others, all of which are seeking scalable innovations that improve scientific validity, transparency, interoperability, and translational reliability across biomedical research.
How much funding would I receive?
Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.
What could I use the funding for?
Funding may support the research, development, validation, implementation, and commercialization of scientific rigor technologies, AI-enabled research infrastructure, reproducibility analytics platforms, metadata systems, and biomedical data science tools.
Eligible activities may include:
AI and machine learning systems for assessing research rigor and reproducibility
Automated protocol standardization and metadata generation platforms
FAIR and TRUST-aligned data interoperability infrastructure
Scientific workflow traceability and provenance tracking technologies
Benchmarking and validation frameworks for AI/ML models
Open science and collaborative research platforms
Common data element (CDE) development and harmonization systems
Biomedical informatics and multimodal data integration tools
Laboratory automation and digital workflow capture technologies
Research reproducibility analytics and variability assessment systems
Clinical trial design optimization and statistical rigor tools
Sex as a biological variable (SABV) reporting and analysis platforms
Genomics, imaging, neuroscience, and environmental health reproducibility tools
Community training, workforce development, and educational technologies
Replication study infrastructure and scientific quality assurance systems
Protocol sharing, versioning, and computational pipeline documentation platforms
Prototype development, translational studies, and validation research
Commercialization planning, implementation scaling, and regulatory preparation activities
Funding may also support personnel, software engineering, cloud infrastructure, AI model development, biomedical data analysis, implementation science, standards development, stakeholder engagement, intellectual property protection, regulatory strategy, and commercialization activities necessary to advance a scalable and commercially viable scientific infrastructure or biomedical research technology solution aligned with NIH priorities.
Are there any additional benefits I would receive?
Beyond the formal funding award, awardees gain several strategic advantages:
Government Validation and Credibility:
Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.Enhanced Visibility and Market Recognition:
Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities.Access to the Federal Innovation Ecosystem:
Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.Stronger Commercial and Exit Potential:
By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment.
What is the timeline to apply and when would I receive funding?
Applications are accepted each year on January 5th, April 5th, and September 5th. Funding is received approximately 9 months after submission.
Where does this funding come from?
Funding comes from the U.S. Department of Health and Human Services, with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.2% for SBIR, 0.45% for STTR) to support small business innovation.
Who is eligible to apply?
Applicants must be U.S. small business concerns (SBCs) that:
Are organized for profit with a U.S. place of business.
Have ≤ 500 employees including affiliates.
Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.
What companies and projects are likely to win?
Projects that demonstrate:
A clear unmet medical or public-health need,
Strong scientific rationale and feasibility,
High commercialization potential, supported by a realistic market and regulatory strategy, and
Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).
Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption.
Are there any restrictions I should know about?
Companies must complete multiple federal registrations (SAM.gov, Grants.gov, eRA Commons, SBA Company Registry) before applying.
Foreign entities are not eligible.
Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation.
How long will it take me to prepare an application?
For a first-time applicant, preparing a competitive submission will likely take 120–200 hours in total.
How can BW&CO help?
Our team specializes in complex federal R&D proposals and can:
Triple your likelihood of success through proven strategy and insider-aligned proposal development
Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations
Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.
